Brinker Capital Investments, LLC Axonics, Inc. Transaction History

Brinker Capital Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2025	SELL	$47.99 - $60.21 $266,488 - $334,346	-5,553 Closed	0 $0
Q1 2023 Jul 31, 2025	SELL	$52.6 - $67.34 $53,546 - $68,552	-1,018 Reduced 15.49%	5,553 $302,000
Q4 2022 Feb 06, 2023	SELL	$59.56 - $76.6 $20,190 - $25,967	-339 Reduced 4.91%	6,571 $410,000
Q3 2022 Nov 01, 2022	BUY	$57.96 - $78.12 $46,715 - $62,964	806 Added 13.2%	6,910 $487,000
Q2 2022 Jul 18, 2022	BUY	$39.5 - $64.42 $71,297 - $116,278	1,805 Added 41.99%	6,104 $346,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $8,004 - $11,485	-183 Reduced 4.08%	4,299 $269,000
Q4 2021 Feb 08, 2022	BUY	$50.01 - $73.35 $224,144 - $328,754	4,482 New	4,482 $251,000

4.99M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.